ArticleCancer immunology, immunotherapy : CII2025

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy.

Anna Reischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.